Navigation Links
Reportlinker Adds Contract Pharmaceutical Manufacturing, Research and Packaging
Date:11/3/2009

RS 63

OTHERS (CONTINUED) 64

OTHERS (CONTINUED) 65

Chapter-12: MARKETS

CONTRACT MANUFACTURING 66

CONTRACT MANUFACTURE OF BULK DRUGS/APIS 66

Market Overview 66

Market Overview (Continued) 67

Market Revenue 68

TABLE 12 WORLDWIDE BULK DRUG/API CONTRACT MANUFACTURING REVENUE BY REGION, THROUGH 2014 ($ BILLIONS) 68

FIGURE 8 WORLDWIDE BULK DRUG/API CONTRACT MANUFACTURING REVENUE BY REGION, 2007-2014 ($ BILLIONS) 69

Market Shares 69

TABLE 13 WORLDWIDE BULK DRUG/API CONTRACT MANUFACTURING MARKET SHARES BY REGION, 2009 (%) 70

FIGURE 9 WORLDWIDE BULK DRUG/API CONTRACT MANUFACTURING MARKET SHARES BY REGION, 2009 (%) 70

CONTRACT MANUFACTURE OF ORAL DOSAGE FORMULATIONS 70

Solid Dosage Formulations 71

Market Overview 71

Market Revenue 72

TABLE 14 WORLDWIDE SOLID DOSAGE FORM CONTRACT MANUFACTURING REVENUE BY REGION, THROUGH 2014 ($ BILLIONS) 73

FIGURE 10 WORLDWIDE SOLID DOSAGE FORM CONTRACT MANUFACTURING REVENUE BY REGION, 2007-2014 ($ BILLIONS) 73

Market Shares 73

TABLE 15 WORLDWIDE SOLID DOSAGE FORM CONTRACT MANUFACTURING MARKET SHARES BY REGION, 2009 (%) 74

FIGURE 11 WORLDWIDE SOLID DOSAGE FORM CONTRACT MANUFACTURING MARKET SHARES BY REGION, 2009 (%) 74

Market by Formulation 75

Market Revenue 75

TABLE 16 WORLDWIDE SOLID DOSAGE FORM CONTRACT MANUFACTURING REVENUE BY FORMULATION, THROUGH 2014 ($ BILLIONS) 76

FIGURE 12 WORLDWIDE SOLID DOSAGE FORM CONTRACT MANUFACTURING REVENUE BY FORMULATION, 2007-2014 ($ BILLIONS) 76

TABLE 17 WORLDWIDE SOLID DOSAGE FORM CONTRACT MANUFACTURING MARKET SHARES BY FORMULATION, 2009 (%) 77

FIGURE 13 WORLDWIDE SOLID DOSAGE FORM CONTRACT MANUFACTURING, MARKET SHARES BY FORMULATION, 2009 (%) 77

Liquid Dosage Formulations 77


'/>"/>

SOURCE Reportlinker
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13

Related medicine technology :

1. Reportlinker Adds Gastrointestinal Pharmaceuticals: Technologies and Markets
2. Reportlinker Adds Chinese Markets for Bladder Cancer Treatment Drugs
3. Reportlinker Adds Chinese Markets for Respiratory Drugs
4. Reportlinker Adds Driving Successful Pharma Brands: Case Studies of Real Product Launches
5. Reportlinker Adds Ion Channel Modulator Pipelines: Targets and Agents in Development
6. Reportlinker Adds Medical Devices & Equipment in India (2009)
7. Reportlinker Adds Outsourcing Preclinical Studies to China
8. Reportlinker Adds Competitor Analysis: PI3K-AKT-mTOR Inhibitors
9. Reportlinker Adds Chugai Pharmaceutical Co. Ltd: PharmaVitae Profile
10. Reportlinker Adds Allergan Inc.: PharmaVitae Profile
11. Reportlinker Adds Pharma 101: An Overview of the Life Sciences Industry (Analyst Insight)
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/30/2015)... SAN DIEGO , July 30, 2015 ... announced it has signed a definitive agreement ... provider of non-invasive ventilation and sleep-disordered breathing ... strong clinical, innovation and market reputation in China, combined with ResMed,s global leadership ... of people in China ...
(Date:7/30/2015)... July 30, 2015  EP Global Communications, Inc. (Public ... recently contacted the Company about discussing EPGL,s electronic ... as Monday, August 3, 2015.  Novartis CEO ... that the coming electronic contact lens market could ... the next several years.  Novartis partnered with Google ...
(Date:7/30/2015)...  Amgen (NASDAQ: AMGN ) today announced ... Key results include: , Total revenues increased ... to $5,370 million, with 6 percent product sales ... Prolia ® (denosumab), Sensipar ® (cinacalcet), ... (denosumab). Unfavorable changes in foreign exchange rates impacted ...
Breaking Medicine Technology:ResMed Invests in High-Growth Chinese Sleep and Respiratory Care Market with Curative Medical 2ResMed Invests in High-Growth Chinese Sleep and Respiratory Care Market with Curative Medical 3Amgen's Second Quarter 2015 Revenues Increased 4 Percent To $5.4 Billion And Adjusted Earnings Per Share (EPS) Increased 8 Percent To $2.57 2Amgen's Second Quarter 2015 Revenues Increased 4 Percent To $5.4 Billion And Adjusted Earnings Per Share (EPS) Increased 8 Percent To $2.57 3Amgen's Second Quarter 2015 Revenues Increased 4 Percent To $5.4 Billion And Adjusted Earnings Per Share (EPS) Increased 8 Percent To $2.57 4Amgen's Second Quarter 2015 Revenues Increased 4 Percent To $5.4 Billion And Adjusted Earnings Per Share (EPS) Increased 8 Percent To $2.57 5Amgen's Second Quarter 2015 Revenues Increased 4 Percent To $5.4 Billion And Adjusted Earnings Per Share (EPS) Increased 8 Percent To $2.57 6Amgen's Second Quarter 2015 Revenues Increased 4 Percent To $5.4 Billion And Adjusted Earnings Per Share (EPS) Increased 8 Percent To $2.57 7Amgen's Second Quarter 2015 Revenues Increased 4 Percent To $5.4 Billion And Adjusted Earnings Per Share (EPS) Increased 8 Percent To $2.57 8Amgen's Second Quarter 2015 Revenues Increased 4 Percent To $5.4 Billion And Adjusted Earnings Per Share (EPS) Increased 8 Percent To $2.57 9Amgen's Second Quarter 2015 Revenues Increased 4 Percent To $5.4 Billion And Adjusted Earnings Per Share (EPS) Increased 8 Percent To $2.57 10Amgen's Second Quarter 2015 Revenues Increased 4 Percent To $5.4 Billion And Adjusted Earnings Per Share (EPS) Increased 8 Percent To $2.57 11Amgen's Second Quarter 2015 Revenues Increased 4 Percent To $5.4 Billion And Adjusted Earnings Per Share (EPS) Increased 8 Percent To $2.57 12Amgen's Second Quarter 2015 Revenues Increased 4 Percent To $5.4 Billion And Adjusted Earnings Per Share (EPS) Increased 8 Percent To $2.57 13Amgen's Second Quarter 2015 Revenues Increased 4 Percent To $5.4 Billion And Adjusted Earnings Per Share (EPS) Increased 8 Percent To $2.57 14Amgen's Second Quarter 2015 Revenues Increased 4 Percent To $5.4 Billion And Adjusted Earnings Per Share (EPS) Increased 8 Percent To $2.57 15Amgen's Second Quarter 2015 Revenues Increased 4 Percent To $5.4 Billion And Adjusted Earnings Per Share (EPS) Increased 8 Percent To $2.57 16Amgen's Second Quarter 2015 Revenues Increased 4 Percent To $5.4 Billion And Adjusted Earnings Per Share (EPS) Increased 8 Percent To $2.57 17Amgen's Second Quarter 2015 Revenues Increased 4 Percent To $5.4 Billion And Adjusted Earnings Per Share (EPS) Increased 8 Percent To $2.57 18Amgen's Second Quarter 2015 Revenues Increased 4 Percent To $5.4 Billion And Adjusted Earnings Per Share (EPS) Increased 8 Percent To $2.57 19Amgen's Second Quarter 2015 Revenues Increased 4 Percent To $5.4 Billion And Adjusted Earnings Per Share (EPS) Increased 8 Percent To $2.57 20Amgen's Second Quarter 2015 Revenues Increased 4 Percent To $5.4 Billion And Adjusted Earnings Per Share (EPS) Increased 8 Percent To $2.57 21Amgen's Second Quarter 2015 Revenues Increased 4 Percent To $5.4 Billion And Adjusted Earnings Per Share (EPS) Increased 8 Percent To $2.57 22Amgen's Second Quarter 2015 Revenues Increased 4 Percent To $5.4 Billion And Adjusted Earnings Per Share (EPS) Increased 8 Percent To $2.57 23
... Sound Surgical Technologies, innovators of ultrasonic body contouring technologies and ...  The original VASER® System was designed to provide patients with smooth, ... a wide array of body contouring applications. , ... Now, the new VASER System has ...
... Solos Endoscopy, Inc. (Pink Sheets: SNDY) is pleased to ... the first quarter ended March 31, 2010 as compared ... a 10 percent increase. As of March 31, 2010 , ... posted its financial results for the first quarter ended March ...
Cached Medicine Technology:Body Contouring Taken to the Next Level 2Body Contouring Taken to the Next Level 3Solos Endoscopy, Inc. Increases Revenues by 10 Percent for First Quarter 2010 as Compared to First Quarter 2009 2
(Date:7/30/2015)... ... July 30, 2015 , ... ... Partners All-Star at the annual All-Stars Summit. Google Partners is the platform for ... may receive the full support and tools necessary to run successful search marketing ...
(Date:7/30/2015)... (PRWEB) , ... July 30, 2015 , ... Between 2012 ... to the Health News Florida on June 17th. Those untreated heroin use ... programs to prevent the spread of dirty needles throughout the community. Ultimately Florida’s HIV ...
(Date:7/30/2015)... ... July 30, 2015 , ... Ocean Hills Recovery has officially been accredited ... “no recommendations.” No recommendations means CARF found no areas in the OHR program that ... than 3% of all facilities receive. In addition, Ocean Hills was granted the maximum ...
(Date:7/30/2015)... ... July 30, 2015 , ... The ... Administrator Chuck Rosenberg’s announcement of the reinstitution of National Prescription Drug Take-Back Days. ... 2015 from 10:00 AM to 2:00 PM local time. On the 26th, the ...
(Date:7/30/2015)... ... July 30, 2015 , ... The ... Cancer Institute Designation , The Tisch Cancer Institute (TCI) at the Icahn School ... cancer center. TCI joins an elite group of 69 cancer institutions nationwide that ...
Breaking Medicine News(10 mins):Health News:Boston Web Marketing Attends Google Partners All-Stars Summit 2Health News:HIV Rates Rise in S. Florida, Harbor Village Comments on Health News Florida's Recent Article 2Health News:HIV Rates Rise in S. Florida, Harbor Village Comments on Health News Florida's Recent Article 3Health News:Ocean Hills Recovery Receives Accreditation from CARF International 2Health News:AAPCC Supports National Prescription Drug Take-Back Day 2Health News:AAPCC Supports National Prescription Drug Take-Back Day 3Health News:The Tisch Cancer Institute at Icahn School of Medicine at Mount Sinai Earns National Cancer Institute Designation 2Health News:The Tisch Cancer Institute at Icahn School of Medicine at Mount Sinai Earns National Cancer Institute Designation 3Health News:The Tisch Cancer Institute at Icahn School of Medicine at Mount Sinai Earns National Cancer Institute Designation 4Health News:The Tisch Cancer Institute at Icahn School of Medicine at Mount Sinai Earns National Cancer Institute Designation 5Health News:The Tisch Cancer Institute at Icahn School of Medicine at Mount Sinai Earns National Cancer Institute Designation 6
... Chinese researchers, the pumpkin promises more than it shows . ... the scientists from East China Normal University, have revealed that ... the pancreas, as well as increase insulin production. ... report in the journal Chemistry and Industry: "Pumpkin extract is ...
... time Terrence Balcita and Chevela Luong were joined as one at ... not enjoying blackjack or Wayne Newton, but that other Vegas specialty: ... to go with the love." Balcita said. ,Couples tied ... enjoy a 7/7/07 wedding date. ,"This is a historic ...
... earlier Rhode Island Hospital study looking at data from ... per year were seen in emergency departments across the ... which examined emergency department visits from 2000 through 2005, ... the study period, an average of 88,563 each year. ...
... Genzyme Corp. announced top-line data from the first of ... and efficacy of tolevamer liquid, an investigational, non-antibiotic , ... (CDAD). The second Phase 3 study of tolevamer liquid ... year. ,In this first Phase 3 study known ...
... a technique that could be used to confirm whether someone ... which has so far been used mainly in animal models, ... abnormal proteins that progressively kill off brain tissue and are ... as known as Protein Misfolding Cyclic Amplification (PMCA), enables the ...
... disorders in sex cells cause infertility, miscarriage and irregular ... ,A new study from Karolinska Institutet published in ... can arise when sex cells are formed. ... mechanism that ensures that the correct numbers of chromosomes ...
Cached Medicine News:Health News:Vegas Couples Hope Sevens Will Be Lucky Wedding Day 2Health News:Higher Rates of Trampoline Injuries 2Health News:Genzyme Announces First Phase III Study of Tolevamer in Diarrhea Patients 2Health News:Significant Advances in VCJD Prion Detection 2
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
Medicine Products: